These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 17372701)

  • 1. Improved protocol and data analysis for accelerated shelf-life estimation of solid dosage forms.
    Waterman KC; Carella AJ; Gumkowski MJ; Lukulay P; MacDonald BC; Roy MC; Shamblin SL
    Pharm Res; 2007 Apr; 24(4):780-90. PubMed ID: 17372701
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The application of the Accelerated Stability Assessment Program (ASAP) to quality by design (QbD) for drug product stability.
    Waterman KC
    AAPS PharmSciTech; 2011 Sep; 12(3):932-7. PubMed ID: 21748541
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmaceutical solid-state kinetic stability investigation by using moisture-modified Arrhenius equation and JMP statistical software.
    Fu M; Perlman M; Lu Q; Varga C
    J Pharm Biomed Anal; 2015 Mar; 107():370-7. PubMed ID: 25656488
    [TBL] [Abstract][Full Text] [Related]  

  • 4. One- and two-stage Arrhenius models for pharmaceutical shelf life prediction.
    Fan Z; Zhang L
    J Biopharm Stat; 2015; 25(2):307-16. PubMed ID: 25358076
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of simultaneous variations in temperature and relative humidity on chemical stability of two vitamin C forms and implications for shelf life models.
    Hiatt AN; Taylor LS; Mauer LJ
    J Agric Food Chem; 2010 Mar; 58(6):3532-40. PubMed ID: 20163110
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A scientific and statistical analysis of accelerated aging for pharmaceuticals. Part 1: accuracy of fitting methods.
    Waterman KC; Swanson JT; Lippold BL
    J Pharm Sci; 2014 Oct; 103(10):3000-6. PubMed ID: 25043838
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of the stability of aspirin in solid state by the programmed humidifying and non-isothermal experiments.
    Li LL; Zhan XC; Tao JL
    Arch Pharm Res; 2008 Mar; 31(3):381-9. PubMed ID: 18409054
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rapid and accurate prediction of degradant formation rates in pharmaceutical formulations using high-performance liquid chromatography-mass spectrometry.
    Darrington RT; Jiao J
    J Pharm Sci; 2004 Apr; 93(4):838-46. PubMed ID: 14999722
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modeling of in-use stability for tablets and powders in bottles.
    Waterman KC; Chen L; Waterman P; MacDonald BC; Monahan AP; Scrivens G
    Drug Dev Ind Pharm; 2016 Oct; 42(10):1571-8. PubMed ID: 27050806
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Arrhenius time-scaled least squares: a simple, robust approach to accelerated stability data analysis for bioproducts.
    Rauk AP; Guo K; Hu Y; Cahya S; Weiss WF
    J Pharm Sci; 2014 Aug; 103(8):2278-86. PubMed ID: 24974956
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Humidity-corrected Arrhenius equation: The reference condition approach.
    Naveršnik K; Jurečič R
    Int J Pharm; 2016 Mar; 500(1-2):360-5. PubMed ID: 26802498
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Shelf-life estimation of pharmaceutical products by matrixing].
    Yoshioka S; Aso Y; Kojima S
    Eisei Shikenjo Hokoku; 1996; (114):143-4. PubMed ID: 9037887
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predicting accelerated aggregation rates for monoclonal antibody formulations, and challenges for low-temperature predictions.
    Brummitt RK; Nesta DP; Roberts CJ
    J Pharm Sci; 2011 Oct; 100(10):4234-43. PubMed ID: 21671226
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparison of drug substance predicted chemical stability with ICH compliant stability studies.
    Williams HE; Bright J; Roddy E; Poulton A; Cosgrove SD; Turner F; Harrison P; Brookes A; MacDougall E; Abbott A; Gordon C
    Drug Dev Ind Pharm; 2019 Mar; 45(3):379-386. PubMed ID: 30395722
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Accelerated Stability Modeling for Peptides: a Case Study with Bacitracin.
    Waterman R; Lewis J; Waterman KC
    AAPS PharmSciTech; 2017 Jul; 18(5):1692-1698. PubMed ID: 27714699
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Generalized regression neural networks in prediction of drug stability.
    Ibrić S; Jovanović M; Djurić Z; Parojcić J; Solomun L; Lucić B
    J Pharm Pharmacol; 2007 May; 59(5):745-50. PubMed ID: 17524242
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quality by design development of brivanib alaninate tablets: degradant and moisture control strategy.
    Badawy SI; Lin J; Gokhale M; Desai S; Nesarikar VV; LaMarche KR; Subramanian GA; Narang AS
    Int J Pharm; 2014 Jul; 469(1):111-20. PubMed ID: 24780101
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantifying crystallisation rates of amorphous pharmaceuticals with dynamic mechanical analysis (DMA).
    Soutari N; Buanz AB; Gul MO; Tuleu C; Gaisford S
    Int J Pharm; 2012 Feb; 423(2):335-40. PubMed ID: 22101291
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Stability of penicillin potassium with linear degradation programmed humidifying experiments].
    He N; Zhan XC; Li LL; Lin B; Tao JL; Jiang L
    Yao Xue Xue Bao; 2007 Aug; 42(8):898-904. PubMed ID: 17944243
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Single time point isothermal drug stability experiments at constant humidity.
    Tao JL; Zhan XC; Li LL; Lin B; Jiang L
    Yakugaku Zasshi; 2009 Mar; 129(3):341-5. PubMed ID: 19252391
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.